Rheumatologist Calls for More Screening of Scleroderma Patients for Pulmonary Hypertension

Author: Joana Fernandes, PhD
Date Published: June-2017
Source: Scleroderma News

Many systemic sclerosis patients develop pulmonary arterial hypertension, but not all who are suspected of having PAH are referred for testing, according to rheumatologist Janet Pope. She called for more commitment to screening in an editorial in Arthritis Research & Therapy. The piece was titled “Pulmonary arterial hypertension in scleroderma: care gaps in screening.” PAH is a lung disease marked by high blood pressure in pulmonary arteries. It can lead to heart failure and death.